These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Lack of inhibition of purine nucleoside phosphorylase and adenosine deaminase in patients treated with azathioprine. Maddocks JL; Al-Safi SA Br J Clin Pharmacol; 1985 Jan; 19(1):108-11. PubMed ID: 3919749 [TBL] [Abstract][Full Text] [Related]
29. Evidence for a pathway independent from 2'-deoxyguanosine and reversible by IL-2 by which purine nucleoside phosphorylase inhibitors block T-cell proliferation. Boehncke WH; Gilbertsen RB; Hemmer J; Sterry W Scand J Immunol; 1994 Mar; 39(3):327-32. PubMed ID: 8128192 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of 9-(5',5'-difluoro-5'-phosphonopentyl)guanine derivatives for PNP-inhibitors. Hikishima S; Isobe M; Koyanagi S; Soeda S; Shimeno H; Shibuya S; Yokomatsu T Bioorg Med Chem; 2006 Mar; 14(5):1660-70. PubMed ID: 16263289 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of human purine nucleoside phosphorylase by acyclic nucleosides and nucleotides. Stein JM; Stoeckler JD; Li SY; Tolman RL; MacCoss M; Chen A; Karkas JD; Ashton WT; Parks RE Biochem Pharmacol; 1987 Apr; 36(8):1237-44. PubMed ID: 3109438 [TBL] [Abstract][Full Text] [Related]
32. N-phosphonocarbonylpyrrolidine derivatives of guanine: a new class of bi-substrate inhibitors of human purine nucleoside phosphorylase. Rejman D; Panova N; Klener P; Maswabi B; Pohl R; Rosenberg I J Med Chem; 2012 Feb; 55(4):1612-21. PubMed ID: 22264015 [TBL] [Abstract][Full Text] [Related]
33. 9-Deazaguanine derivatives: synthesis and inhibitory properties as multi-substrate analogue inhibitors of mammalian PNPs. Yatsu T; Hashimoto M; Hikishima S; Magnowska L; Bzowska A; Yokomatsu T Nucleic Acids Symp Ser (Oxf); 2008; (52):661-2. PubMed ID: 18776553 [TBL] [Abstract][Full Text] [Related]
34. PD 141955 and CI-972: 9-deazaguanine analog purine nucleoside phosphorylase inhibitors. II. Effects on nucleoside catabolism in human and rat blood in vitro. Dong MK; Gilbertsen RB Agents Actions; 1993; 39 Spec No():C99-101. PubMed ID: 8273600 [TBL] [Abstract][Full Text] [Related]
35. Structure-based design of inhibitors of purine nucleoside phosphorylase. 3. 9-Arylmethyl derivatives of 9-deazaguanine substituted on the methylene group. Erion MD; Niwas S; Rose JD; Ananthan S; Allen M; Secrist JA; Babu YS; Bugg CE; Guida WC; Ealick SE J Med Chem; 1993 Nov; 36(24):3771-83. PubMed ID: 8254607 [TBL] [Abstract][Full Text] [Related]
36. Kinetics of binding of multisubstrate analogue inhibitor (2-amino-9-[2-(phosphonomethoxy)ethyl]-6-sulfanylpurine) with trimeric purine nucleoside phosphorylase. Antosiewicz J; Wielgus-Kutrowska B; Długosz M; Holy A; Bzowska A Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):969-74. PubMed ID: 18058519 [TBL] [Abstract][Full Text] [Related]
37. The purine nucleoside phosphorylase from Trichomonas vaginalis is a homologue of the bacterial enzyme. Munagala N; Wang CC Biochemistry; 2002 Aug; 41(33):10382-9. PubMed ID: 12173924 [TBL] [Abstract][Full Text] [Related]
38. Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes. Kicska GA; Long L; Hörig H; Fairchild C; Tyler PC; Furneaux RH; Schramm VL; Kaufman HL Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4593-8. PubMed ID: 11287638 [TBL] [Abstract][Full Text] [Related]
39. Synthesis of second-generation transition state analogues of human purine nucleoside phosphorylase. Evans GB; Furneaux RH; Lewandowicz A; Schramm VL; Tyler PC J Med Chem; 2003 Nov; 46(24):5271-6. PubMed ID: 14613329 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and evaluation of 9-deazaguanine derivatives as multi-substrate analogue inhibitors of PNP. Hashimoto M; Hikishima S; Magnowska L; Bzowska A; Yokomatsu T Nucleic Acids Symp Ser (Oxf); 2007; (51):431-2. PubMed ID: 18029771 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]